Literature DB >> 15192021

Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY.

Sarah L Sayner1, Dara W Frank, Judy King, Hairu Chen, John VandeWaa, Troy Stevens.   

Abstract

Mammalian transmembrane adenylyl cyclases synthesize a restricted plasmalemmal cAMP pool that is intensely endothelial barrier protective. Bacteria have devised mechanisms of transferring eukaryotic factor-dependent adenylyl cyclases into mammalian cells. Pseudomonas aeruginosa ExoY is one such enzyme that catalyzes cytosolic cAMP synthesis, with unknown function. Pseudomonas aeruginosa genetically modified to introduce only the ExoY toxin elevated cAMP 800-fold in pulmonary microvascular endothelial cells over 4 hours, whereas a catalytically deficient (ExoY(K81M)) strain did not increase cAMP. ExoY-derived cAMP was localized to a cytosolic microdomain not regulated by phosphodiesterase activity. In contrast to the barrier-enhancing actions of plasmalemmal cAMP, the ExoY cytosolic cAMP pool induced endothelial gap formation and increased the filtration coefficient in the isolated perfused lung. These findings collectively illustrate a previously unrecognized mechanism of hyperpermeability induced by rises in cytosolic cAMP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192021     DOI: 10.1161/01.RES.0000134922.25721.d9

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  59 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Authors:  David M Anderson; Katherine M Schmalzer; Hiromi Sato; Monika Casey; Scott S Terhune; Arthur L Haas; Jimmy B Feix; Dara W Frank
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

Review 3.  Role of soluble adenylyl cyclase in the heart.

Authors:  Jonathan Chen; Lonny R Levin; Jochen Buck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

Review 4.  The multiple signaling systems regulating virulence in Pseudomonas aeruginosa.

Authors:  Pol Nadal Jimenez; Gudrun Koch; Jessica A Thompson; Karina B Xavier; Robbert H Cool; Wim J Quax
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

5.  Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance.

Authors:  Kevin Lowe; Diego F Alvarez; Judy A King; Troy Stevens
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

6.  cCMP and cUMP occur in vivo.

Authors:  Heike Bähre; Christina Hartwig; Antje Munder; Sabine Wolter; Tane Stelzer; Bastian Schirmer; Ulrike Beckert; Dara W Frank; Burkhard Tümmler; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2015-03-31       Impact factor: 3.575

7.  Soluble adenylyl cyclase-dependent microtubule disassembly reveals a novel mechanism of endothelial cell retraction.

Authors:  Nutan Prasain; Mikhail Alexeyev; Ron Balczon; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-24       Impact factor: 5.464

8.  Filamin A is a phosphorylation target of membrane but not cytosolic adenylyl cyclase activity.

Authors:  Sarah L Sayner; Ron Balczon; Dara W Frank; Dermot M F Cooper; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-08       Impact factor: 5.464

9.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

10.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.